David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
976
DELISTED
Dynavax Technologies
DVAX
| $7.88M | 0.01% |
409,653
+268,970
| +191% | +$5.44M |
|
|
SPPI
977
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $7.88M | 0.01% |
1,238,760
+251,650
| +25% | +$1.29M |
|
978
BlackBerry
BB
$4.57B
| $7.87M | 0.01% |
973,304
-2,991,935
| -75% | -$22.4M |
|
979
Stride
LRN
$3.56B
| $7.87M | 0.01% |
796,096
-106,255
| -12% | -$1M |
|
980
NetEase
NTES
$82.5B
| $7.85M | 0.01% |
273,415
-798,130
| -74% | -$23.9M |
|
|
SWNC
981
DELISTED
Southwestern Energy Company
SWNC
| $7.84M | 0.01% |
402,610
-695,400
| -63% | -$12.8M |
|
982
PUT
Valero Energy
VLO
$98B
| $7.84M | 0.01% |
122,200
-295,500
| -71% | -$18.8M |
|
|
GTS
983
DELISTED
Triple-S Management Corporation
GTS
| $7.81M | 0.01% |
330,214
+57,974
| +21% | +$1.3M |
|
|
ARG
984
CALL
DELISTED
Airgas Inc
ARG
| $7.79M | 0.01% |
+55,000
| New | +$7.72M |
|
|
PAY
985
DELISTED
Verifone Systems Inc
PAY
| $7.73M | 0.01% |
273,761
+199,148
| +267% | +$4.92M |
|
|
TRQ
986
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $7.7M | 0.01% |
303,207
-43,227
| -12% | -$976K |
|
987
Tidewater
TDW
$4.59B
| $7.69M | 0.01% |
34,889
+13,551
| +64% | +$2.68M |
|
|
CAJ
988
DELISTED
Canon, Inc.
CAJ
| $7.65M | 0.01% |
256,588
+60,526
| +31% | +$1.74M |
|
|
NTRI
989
DELISTED
NutriSystem, Inc.
NTRI
| $7.65M | 0.01% |
366,388
+210,983
| +136% | +$4.17M |
|
990
CALL
Under Armour
UAA
$2.2B
| $7.63M | 0.01% |
180,000
-211,800
| -54% | -$8.36M |
|
|
SCLN
991
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $7.62M | 0.01% |
692,674
+49,285
| +8% | +$438K |
|
|
MGLN
992
DELISTED
Magellan Health Services, Inc.
MGLN
| $7.61M | 0.01% |
112,077
-36,253
| -24% | -$2.18M |
|
|
AEL
993
DELISTED
American Equity Investment Life Holding Company
AEL
| $7.6M | 0.01% |
452,510
+347,819
| +332% | +$5.64M |
|
994
Monolithic Power Systems
MPWR
$64.1B
| $7.57M | 0.01% |
118,909
-2,963
| -2% | -$177K |
|
995
Ubiquiti
UI
$34.9B
| $7.56M | 0.01% |
227,359
+99,509
| +78% | +$3.09M |
|
996
Grand Canyon Education
LOPE
$3.89B
| $7.56M | 0.01% |
176,856
+57,754
| +48% | +$2.23M |
|
997
National Health Investors
NHI
$3.6B
| $7.5M | 0.01% |
112,786
+51,748
| +85% | +$3.2M |
|
|
ORBK
998
DELISTED
Orbotech Ltd
ORBK
| $7.5M | 0.01% |
315,356
-72,555
| -19% | -$1.58M |
|
999
Signet Jewelers
SIG
$3.29B
| $7.49M | 0.01% |
60,400
-261,238
| -81% | -$29.7M |
|
1000
Antero Resources
AR
$11.7B
| $7.49M | 0.01% |
301,182
+195,908
| +186% | +$4.71M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.